MARCY L’ETOILE, France & SUNDERLAND, England--(BUSINESS WIRE)--Regulatory News: A team of researchers from the University of Sunderland and bioMérieux (Paris:BIM), a leading company in the field of in vitro diagnostics, have achieved a new step in the fight against Pseudomonas aeruginosa, a bacterium responsible for deadly healthcare-associated infections, which kills tens of thousands of people throughout the world every year1.
